| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 293,6 k € | +25.7% | 233,6 k € | -44.5% | 420,5 k € | +76.8% | 237,8 k € | -25.0% | 317,0 k € | +1415.3% | 20,9 k € | -48.5% | 40,6 k € | +507.9% | 6,7 k € | +363.9% | -2,5 k € | -55.1% | -1,6 k € | +6.2% | -1,7 k € | +32.5% | -2,6 k € | |
| EBITDA | 248,5 k € | +34.3% | 185,1 k € | -51.5% | 381,5 k € | +71.0% | 223,2 k € | -28.1% | 310,2 k € | +1408.2% | 20,6 k € | -48.8% | 40,2 k € | +541.5% | 6,3 k € | +317.5% | -2,9 k € | -45.4% | -2,0 k € | +5.1% | -2,1 k € | +19.0% | -2,6 k € | |
| Operating profit | 246,4 k € | +35.1% | 182,4 k € | -52.0% | 379,6 k € | +71.4% | 221,4 k € | -28.5% | 309,8 k € | +1406.3% | 20,6 k € | -48.8% | 40,2 k € | +649.1% | 5,4 k € | +286.3% | -2,9 k € | -45.4% | -2,0 k € | +5.1% | -2,1 k € | +35.1% | -3,2 k € | |
| Profit/loss | 180,4 k € | +35.5% | 133,1 k € | -47.7% | 254,7 k € | +78.8% | 142,5 k € | -35.5% | 220,7 k € | +1608.4% | 12,9 k € | -49.8% | 25,7 k € | +472.9% | 4,5 k € | +255.9% | -2,9 k € | -45.4% | -2,0 k € | +5.1% | -2,1 k € | +35.1% | -3,2 k € | |
| Equity | 285,9 k € | -51.6% | 590,6 k € | +11.8% | 528,4 k € | +60.7% | 328,8 k € | +48.6% | 221,3 k € | +558.9% | 33,6 k € | +62.5% | 20,7 k € | +59.9% | 12,9 k € | +53.3% | 8,4 k € | +215.8% | -7,3 k € | -37.4% | -5,3 k € | -65.0% | -3,2 k € | |
| Total assets | 798,9 k € | +15.7% | 690,6 k € | +17.3% | 588,8 k € | +50.8% | 390,6 k € | +44.0% | 271,3 k € | +77.3% | 153,0 k € | +105.9% | 74,3 k € | +448.6% | 13,6 k € | -27.1% | 18,6 k € | — | — | — | ||||
| Cash | 529,9 k € | +789.3% | 59,6 k € | +401.4% | 11,9 k € | -96.0% | 298,7 k € | +20.4% | 248,1 k € | +372.8% | 52,5 k € | +39.6% | 37,6 k € | +177.3% | 13,6 k € | -27.1% | 18,6 k € | — | — | — | ||||
| Debts | 513,0 k € | +412.6% | 100,1 k € | +65.7% | 60,4 k € | -2.3% | 61,8 k € | +23.6% | 50,0 k € | -58.1% | 119,5 k € | +122.5% | 53,7 k € | +8497.8% | 624,3 € | -93.9% | 10,2 k € | +39.6% | 7,3 k € | +37.4% | 5,3 k € | +65.0% | 3,2 k € | |
Private limited company · Fernelmont · incorporated on 10/09/2013
Private limited company profitable and well capitalised. Cash position rising (+789.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDIRESEARCH is a Private limited company incorporated in 2013. Its main activity is: Other human health activities. Its registered office is in Fernelmont.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette